搜索结果

Search Results for " mtorc1-in-1 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T81743	mTORC1-IN-1	mTOR	PI3K/Akt/mTOR signaling
	mTORC1-IN-1（compound T1）为一种rapalog及选择性mTORC1抑制剂，调节细胞生长和代谢，与多种疾病如癌症相关。该化合物通过与FKBP12-FRB复合物结合（对接分数−11.6 kcal/mol）来靶向mTORC1。
T61831	NS1-IN-1	Influenza Virus	Microbiology/Virology
	NS1-IN-1 是一种有效的NS1抑制剂。NS1-IN-1 通过以 TSC1-TSC2 依赖性方式抑制 mTORC1 的活性来显示抗病毒活性。NS1-IN-1 降低病毒蛋白水平，有助于减少病毒复制。
T35343	MTI-31 MTI-31,LXI-15029	mTOR	PI3K/Akt/mTOR signaling
	MTI-31 (LXI-15029) 是口服有效的，高度选择性的mTORC1和mTORC2抑制剂，对 mTOR 的Kd 为 0.20 nM，IC50为 39 nM。MTI-31可用于乳腺癌的研究。
T73224	AMPK-IN-1
	AMPK-IN-1 是一种 AMPK 激活剂 (对亚型α2β2γ1的 EC50为 551 nM)。AMPK-IN-1 可导致 eEF2 的 mTORC1-非依赖性磷酸化。
T60265	NV-5138 hydrochloride
	NV-5138 hydrochloride 是一种亮氨酸类似物，是一个具有选择性和口服活性的脑内的mTORC1的激动剂，可与 Sestrin2 结合。NV-5138 hydrochloride 可用于抗抑郁的研究。
T36535	SEC
	SEC activates ANXA7 GTPase through the AMPK/mTORC1/STAT3 signaling pathway. It selectively induces apoptosis in cancer cells expressing high levels of ITGB4 by promoting ITGB4 nuclear translocation [1][2].
T79464	RORγ antagonist 1	ROR	Metabolism
	RORγ antagonist1 (化合物22) 作为RORγ的有效拮抗剂 (KD=0.18 μM)，在HPAF-II胰腺癌异种移植模型中显示出了抗增殖性能。该化合物通过抑制RAS/MAPK和AKT/mTORC1通路，并引发caspase依赖的细胞凋亡(apoptosis)机制，从而在胰腺癌细胞中发挥作用。
T61659	CC214-2
	CC214-2 is a potent dual inhibitor of mTORC1 and mTORC2, known for its ability to impede autophagy by modulating mammalian target of rapamycin (mTOR) signaling. With this capacity, CC214-2 shows promise in shortening the duration of tuberculosis (TB) [1].
T36108	YW3-56 (hydrochloride) (technical grade) YW3-56 (hydrochloride) (technical grade)
	YW3-56 is an inhibitor of protein arginine deiminase 2 (PAD2) and PAD4 (IC50s = 0.5-1 and 1-5 μM, respectively).1It inhibits the growth of U2OS osteosarcoma cells (IC50= ~2.5 μM) in a p53-dependent mannerviainduction of SESN2 and subsequent inhibition of mTORC1. YW3-56 (10 mg/kg) reduces tumor growth in an S-180 murine sarcoma tumor model. It also inhibits tumor growth in the 1883 MDA-MB-231 breast cancer bone metastasis mouse xenograft model.2 1.Wang, Y., Li, P., Wang, S., et al.Anticancer pept...
T35874	CC260
	CC260 is a selective PI5P4Kα and PI5P4Kβ inhibitor with Kis of 40 nM and 30 nM, respectively. CC260 does not inhibit or weakly inhibits other protein kinases, such as Plk1 and RSK2. CC260 can be used for cell energy metabolism, diabetes and cancer research[1]. In cultured C2C12 myotubes, CC260 (20 μM) enhances Insulin-induced Akt phosphorylation at both Thr-308 and Ser-473 but suppresses S6K phosphorylation (Thr-389) by mTORC1[1]. CC260 (2.5 μM, 5 μM, 10 μM, 20 μM) significantly increases phosph...